Molecular Testing for Infectious Diseases Market Study Offering Deep Insight Related to Growth and Trends until 2030

Wilmington, Delaware, United States, Transparency Market Research Inc.: Diagnostic testing is the backbone of a successful health care system which provides exact information that patients and health care providers need to make the right medical decisions. Diagnostics also offer accurate, quantitative metrics that guide the prevention, prediction, diagnosis, care, and effective management of health problems at any level.

Read Report Overview - https://www.transparencymarketresearch.com/molecular-testing-for-infectious-diseases-market.html

Molecular testing is a revolutionary and complex diagnostic field, contributing to understandings of many disease-revolutionizing health care systems in study and diagnosis. Molecular testing identifies and tests the involvement of proteins or genetic material associated with a particular clinical disorder or illness, seeks to reveal the root causes of the disease and allows physicians to adapt patient treatment and promote the practice of ‘personalized medicine’.

Technological advancements coupled with government funding are expected to trigger the growth of the global molecular testing for infectious diseases market. Additionally, reduction in time and cost coupled with increase in need of customized molecular testing for infectious diseases augments the global molecular testing for infectious diseases market.

Request for Report Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=76864

Key Drivers and Restraints of Global Molecular Testing for Infectious Diseases Market

Rise in Prevalence of Infectious Diseases

According to the WHO infectious disease surveillance data, infectious diseases such as gonorrhea, tuberculosis, campylobacteriosis, covid-19 or coronavirus, and salmonellosis account for a majority of the infectious diseases throughout the globe, and E. coli infection is the most common food-related infection.

Thus, rise in prevalence of infectious diseases is likely to contribute to the growth of the molecular testing for infectious diseases market as these tests are among the most preferred methods for the detection of these diseases.

Increase in Public and Private Funding

The molecular testing for infectious diseases market witnessed a surge in funding that has expanded the real-time PCR research. Participants from different industries have funded several real-time PCR projects in academic and research institutions.

Further, Europa Organisation, the European funding organization, supports innovative companies in the development of new products and conducts annual PCR conferences to identify potential innovators of PCR technology

Similarly, in July 2016, Mobidiag Oy, a Finland-based molecular diagnostic company, received EUR 15 Mn loan (US$ 16.5 Mn) from European Investment Bank (EIB). This funding is expected to enable Mobidiag Oy to enhance its Amplidiag system, which includes multiplex tests for gastrointestinal infections. These tests employ real-time PCR to generate results.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=76864

Insulin Infusion Pumps Segment to Dominate Global Market

In terms of application, the global molecular testing for infectious diseases market can be classified into HIV, hepatitis, sepsis, respiratory diseases, tuberculosis, sexually transmitted diseases, and others

Based on test type, the global molecular testing for infectious diseases market can be categorized into polymerase chain reaction, mass spectrometry, transcription mediated, amplification (TMA), hybridization, and others

Based on end-user, the global molecular testing for infectious diseases market can be divided into hospitals, research & academic institutes, diagnostic laboratories, and others

Europe to Dominate Global Molecular Testing for Infectious Diseases Market by End of Forecast Period

In terms of region, the global molecular testing for infectious diseases market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

The molecular testing for infectious disease market is largely centered in the U.S. The country’s dominance is due to major players such as Agilent Technologies and Abbott Laboratories that are based in the U.S.

The U.S accounts for significant market share; however, it is anticipated to be overtaken by Europe, owing to the rise in number of manufacturers in the region. Moreover, the molecular testing for infectious diseases market in Europe is witnessing a high growth rate due to increase in prevalence of infectious diseases, advancements in molecular techniques, and growing awareness and acceptance of personalized medicine and companion diagnostics.

Molecular diagnostics of infectious diseases, in particular, nucleic-acid-based methods, are the fastest growing field in clinical laboratory diagnostics. These applications are stepwise replacing or complementing biochemical, culture-based, and immunological assays in microbiology laboratories.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=76864

Leading Players Operating in Global Molecular Testing for Infectious Diseases Market

The global molecular testing for infectious diseases market was highly fragmented in 2019. Key players operating in the global molecular testing for infectious diseases market are:

  • Abbott
  • Agilent Technologies, Inc.
  • Alere, Inc.
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Cepheid.
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Meridian Bioscience, Inc.
  • PerkinElmer, Inc.
  • Randox Laboratories, Ltd.
  • QIAGEN
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.

More Trending Reports by Transparency Market Research –

Bone Graft Substitutes Market: the global bone graft substitutes market was valued at US$ 2.9 Bn in 2019 and is anticipated to expand at a CAGR of 3.4% from 2020 to 2030

Corporate Wellness Market: The Asia Pacific corporate wellness market is expected to cross the value of US$ 8.6 Bn by the end of 2028.

Medical Holography Market: The global medical holography market was valued at around US$ 240.0 Mn in 2017 and is anticipated to reach around US$ 3500.0 Mn by 2026.

Aseptic Transfer System Market: The global aseptic transfer system market is expected to cross the value of US$ 2.1 Bn by the end of 2031.

MAE Direct to Consumer Laboratory Testing Market: The MEA direct-to-consumer laboratory testing market is expected to expand at a CAGR of 18.3% during the forecast period.

Glycomics Market: The global glycomics market is projected to cross US$ 3.1 Bn by 2031. The increasing demand for treatments for various chronic diseases is fueling the growth of the global glycomics market.

Serum free Media Market: The global serum-free media market was valued at US$ 320 Mn in 2020 and is anticipated to expand at a CAGR of 7% from 2021 to 2031.

Baby & Pregnancy Skincare Products Market: The global baby & pregnancy skincare products market is projected to grow at a CAGR of 6.9% during the forecast period.

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

Back to news